Skip to main content
FinSpry Logo
FinSpry
A
AKTS
(NASDAQ)
Aktis Oncology, Inc.
$18.50-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Aktis Oncology (AKTS) Stock Price & Financial Analysis

Aktis Oncology Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$18.57 - $19.76
52-Week High$29.16
52-Week Low$14.72
Open$19.50
Volume155.83K
Average Volume (3M)213.30K
Market Cap15.90M
Shares Outstanding813.52K
Price to Sales (P/S)2.45
Price to Book (P/B)0.08
EV/EBITDA0.14
Revenue (TTM)6.50M
Net Income (TTM)-63.73M
Free Cash Flow (TTM)-73.71M
EPS (TTM)$-78.34
Profit Margin-980.93%
Operating Margin-1149.52%
Return on Equity (ROE)-34.03%
Debt to Equity0.06
50-Day MA$18.76
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Aktis Oncology

What is the current stock price for AKTS?

As of the latest trading session, AKTS stock trades at $18.61. The 52-week range is $14.72–$29.16, with a day range of $18.57–$19.76.

What is the P/E ratio for AKTS?

The P/E ratio (Price-to-Earnings) for AKTS is shown in the Key Statistics section. This valuation metric helps compare Aktis Oncology, Inc. to industry peers.

Does AKTS pay dividends?

Aktis Oncology does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for AKTS?

Based on 2 analysts, the consensus for AKTS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of AKTS?

Aktis Oncology's market capitalization is $15.1M, classifying it as a micro-cap company. Aktis Oncology operates in the Healthcare sector within the Biotechnology industry.